NPPA Approves 50 percent Price Increase of 8 essential drugs, details MD Bureau15 Oct 2024 1:38 PM ISTDelhi: The National Pharmaceutical Pricing Authority (NPPA) has announced a 50% increase in the ceiling prices of eleven scheduled formulations...
DCGI bans this popular anti-cold FDC for children under 4 Farhat Nasim14 Oct 2024 4:25 PM ISTNew Delhi: The Drug Controller General of India (DCGI) has banned use of popular anti-cold cocktail medicine combination for children under four years...
Rs 9.81 crore expenditure on Conference fees, accommodation to doctors, Business Promotion done by Sun Pharma disallowed:Â ITÂ Tribunal Farhat Nasim13 Oct 2024 12:15 PM ISTAhmedabad: The Income Tax Appellate Tribunal (ITAT) in Ahmedabad has upheld the disallowance of more than Rs 9.81 crore incurred by Sun Pharma...
Anti cancer medicines now under Schedule H2 of Drugs Rules, Here is what it means Farhat Nasim12 Oct 2024 12:30 PM ISTNew Delhi: In order to track the movement of anti-cancer drugs and prevent counterfeiting, the Drug Technical Advisory Board (DTAB) has agreed to...
Soon, harsher penalties for submitting false data for drug approval Farhat Nasim11 Oct 2024 3:04 PM ISTNew Delhi: Soon, there will be a stringent action against pharma companies who submit forged or false data for drug approval for sales in the...
Pharma-sponsored Indian CMEs allowed, but Govt sets speaker-to-participant ratios for such events Farhat Nasim10 Oct 2024 4:08 PM ISTNew Delhi: Noting that pharma-sponsored Continuing Medical Education (CME)/ Continuing Professional Development (CPD) programs that are being...
Submit efficacy data of Indian population: CDSCO Panel Tells Eli Lilly for approval of additional indications of Ixekizumab Dr. Divya Colin9 Oct 2024 6:00 PM ISTNew Delhi: Citing that there is no efficacy data in the Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Pfizer Gets CDSCO Panel Nod to Study PF-06823859 Dr. Divya Colin8 Oct 2024 6:00 PM ISTNew Delhi:The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun's RACIRAFT Vs JB Pharma's RANRAFT: Delhi HC gives interim trademark protection to Sun Pharma Farhat Nasim7 Oct 2024 6:07 PM ISTNew Delhi: In a respite to drug major Sun Pharmaceutical Industries Ltd, the Delhi High Court has granted an interim injunction restraining JB...
Sun Pharmaceutical Industry gets CDSCO Panel nod to study Aflibercept Injection Dr. Divya Colin6 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Tetracycline Susmita Roy5 Oct 2024 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September, has revealed that the...
Exemed Pharmaceuticals gets CDSCO Panel nod to study Sacubitril plus Valsartan film-coated sustained release tablet Dr. Divya Colin4 Oct 2024 6:00 PM ISTNew Delhi: Reviewing the justification for the variability of the kinetic data of the bioequivalence (BE) study report of the fixed-dose combination...
